Ribavirin
Synonyms: RBV, 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide, 1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
Tags:
drug
small molecule
approved
PubChem: 37542 37542 DrugBank: DB00811, APRD00081, EXPT02825, DB01693 DB00811, APRD00081, EXPT02825, DB01693 ATC: J05AP01 J05AP01 Related interactions
Related publications
Title
Author
Type
Discovering drugs to treat coronavirus disease 2019 (COVID-19). Liying Dong, Shasha Hu, Jianjun Gao
Research
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, Wang Q, Xu Y, Li M, Li X, Zheng M, Chen L, Li H
Research
Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs Ujjwal Neogi, Kyle J. Hill, Anoop T Ambikan, Xiao Heng, Thomas P. Quinn, Siddappa N. Byrareddy, Anders Sönnerborg, Stefan G. Sarafianos, Kamal Singh
Research
Old and re-purposed drugs for the treatment of COVID-19 Shio-Shin Jean, Po-Ren Hsueh
Review
A comprehensive review on drug repositioning against coronavirus disease 2019 (COVID19) Maryam Rameshrad, Majid Ghafoori, Amir Hooshang Mohammadpour, Mohammad Javad Dehghan Nayeri & Hossein Hosseinzadeh
Review
Accelerating drug development through repurposed FDA approved drugs for COVID-19: speed is important, not haste James T. Gordy, Kaushiki Mazumdar, Noton K. Dutta
Other
Review of trials currently testing treatment and prevention of COVID-19. P. C. Fragkou, D. Belhadi, N. Peiffer-Smadja, C. D. Moschopoulos, F. X. Lescure, H. Janocha, E. Karofylakis, Y. Yazdanpanah, F. Mentré, C. Skevaki, C. Laouénan, S. Tsiodras
Review
Identification of Drugs Targeting Multiple Viral and Human Proteins Using Computational Analysis for Repurposing Against COVID-19 Sugandh Kumar, Pratima Kumari, Geetanjali Agnihotri, Preethy VijayKumar, Shaheerah Khan, Gulam Hussain Syed, Anshuman Dixit
Research
Investigation of Some Antiviral N-Heterocycles as COVID 19 Drug: Molecular Docking and DFT Calculations Mohamed Hagar, Hoda A. Ahmed, Ghadah Aljohani, Omaima A. Alhaddad
Research
Transcriptome-based drug repositioning for coronavirus disease 2019 (COVID-19) Zhilong Jia, Xinyu Song, Jinlong Shi, Weidong Wang, Kunlun He
Research
Identifying Effective Antiviral Drugs Against SARS-CoV-2 by Drug Repositioning Through Virus-Drug Association Prediction Lihong Peng, Xiongfei Tian, Ling Shen, Ming Kuang, Tianbao Li, Geng Tian, Jialiang Yang, Liqian Zhou
Research
Target
Target affiliation
Drug
Type
Result
Target
Target affiliation
Drug
Type
Result
Name
Synonyms
Genes
Origin
Name
Synonyms
Genes
Origin
Name
Synonyms
PubChem
DrugBank
RCSB PDB
ATC
Name
Synonyms
PubChem
DrugBank
RCSB PDB
ATC
Title
Authors
DOI
Source
Article type
Date
Title
Authors
DOI
Source
Article type
Date
Title
Status
Phases
Start Date
Prim. Comp. Date
Comp. Date
First Post. Date
Title
Status
Phases
Start Date
Prim. Comp. Date
Comp. Date
First Post. Date
CORDITE (CORona Drug InTEractions database) collects and aggregates data from PubMed, MedRxiv, BioRxiv, ChemRxiv and PMC for SARS-CoV-2. Its main focus is set on drug interactions either addressing viral proteins or human proteins that could be used to treat COVID.
It collects and provides up-to-date information on computational predictions, in vitro, as well as in vivo study data.
The information provided is for research only and we cannot guarantee the correctness of the data.
Please contact dominik.heider@uni-muenster.de for further information.
Programmable access
There is an open API for access programmatically to the database. The API will print a JSON output:
Interactions
https://cordite-api.uni-muenster.de/api.php?action=list&table=interaction Targets
https://cordite-api.uni-muenster.de/api.php?action=list&table=target Drugs
https://cordite-api.uni-muenster.de/api.php?action=list&table=drug Publications
https://cordite-api.uni-muenster.de/api.php?action=list&table=publication Clinical trials
https://cordite-api.uni-muenster.de/api.php?action=list&table=clinical_trial
